Ramireddy Bommireddy, PhD, MSc

Research Program

Discovery and Developmental Therapeutics
Phone Number

404-727-6741
Email Address

ramireddy.bommireddy@emory.edu

Biography

Ramireddy Bommireddy, PhD, MSc, is an instructor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. Dr. Bommireddy is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute.

Education

Dr. Bommireddy earned his PhD from Indian Institute of Science in Bangalore, India. He also earned his MSc in Animal Sciences and completed postdoctoral training in viral immunology at University of Hyderabad in India. He then completed postdoctoral training in autoimmunity at University of Cincinnati in Cincinnati, Ohio.

Titles & Roles

Instructor, Department of Pathology and Laboratory Medicine

Emory University School of Medicine

Research

Dr. Bommireddy's main research focus is to understand the molecular mechanism underlying in inflammatory autoimmune responses and cancer as it relates to tolerance to self-antigens and tumor induced immunosuppression or immune senescence.

Title/Journal	Authors	Publication Date
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice. Immunity & ageing : I & A	BR Park, R Bommireddy, DH Chung, KH Kim, J Subbiah, YJ Jung, N Bhatnagar, CD Pack, S Ramachandiran, SJC Reddy, P Selvaraj, SM Kang	11/05/2023
The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy. Frontiers in immunology	H Zhang, T Passang, S Ravindranathan, R Bommireddy, MR Jajja, L Yang, P Selvaraj, CM Paulos, EK Waller	01/01/2023
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses. Vaccines	R Bommireddy, S Stone, N Bhatnagar, P Kumari, LE Munoz, J Oh, KH Kim, JTL Berry, KM Jacobsen, L Jaafar, SH Naing, AN Blackerby, TV Gaag, CN Wright, L Lai, CD Pack, S Ramachandiran, MS Suthar, SM Kang, M Kumar, SJC Reddy, P Selvaraj	14/06/2022
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy. Journal for immunotherapy of cancer	LE Munoz, L Huang, R Bommireddy, R Sharma, L Monterroza, RN Guin, SG Samaranayake, CD Pack, S Ramachandiran, SJC Reddy, M Shanmugam, P Selvaraj	01/11/2021
Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer Models. International journal of molecular sciences	LE Munoz, L Monterroza, R Bommireddy, Y Shafizadeh, CD Pack, S Ramachandiran, SJC Reddy, P Selvaraj	04/08/2021
Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor. PloS one	L Huang, R Bommireddy, LE Munoz, RN Guin, C Wei, A Ruggieri, AP Menon, X Li, M Shanmugam, TK Owonikoko, SS Ramalingam, P Selvaraj	01/01/2021
Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer. Human vaccines & immunotherapeutics	CD Pack, R Bommireddy, LE Munoz, JM Patel, EN Bozeman, P Dey, V Radhakrishnan, VF Vartabedian, K Venkat, S Ramachandiran, SJC Reddy, P Selvaraj	01/12/2020
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines	R Bommireddy, LE Munoz, A Kumari, L Huang, Y Fan, L Monterroza, CD Pack, S Ramachandiran, SJC Reddy, J Kim, ZG Chen, NF Saba, DM Shin, P Selvaraj	14/04/2020